An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive survival outcomes in patients with resected pancreatic and colorectal cancers, ...

The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...

MARTHA’S VINEYARD, MASSACHUSETTS – AUGUST 07: Congresswoman Jasmine Crockett speaks during The Color of Conversation during ...

When HHS Secretary Robert Kennedy Jr. terminated nearly $500 million in mRNA research last week, he didn’t just cripple our ...